Concepedia

Emiri Nakazawa

EN

9

Publications

462

Citations

9

H-Index

2006

Active since

Affiliations

Sapporo Medical University(Current)

Japan Science and Technology Agency

Keiyukai Sapporo Hospital

University of Pennsylvania

Sumitomo Dainippon Pharma (Japan)

Emiri Nakazawa is an author at Sapporo Medical University specializing in medicine, cancer research, and radiation oncology.

Top concepts

Publications per year

2006–2013

9

Publications

9

Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5

Tomohide Tsukahara, Satoshi Kawaguchi, Toshihiko Torigoe et al. · Cancer Science · 2006 · 142 citations · Full text

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma

Satoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Journal of Immunotherapy · 2009 · 90 citations

Establishment of a monoclonal anti‐pan HLA class I antibody suitable for immunostaining of formalin‐fixed tissue: Unusually high frequency of down‐regulation in breast cancer tissues

Toshihiko Torigoe, Hiroko Asanuma, Emiri Nakazawa et al. · Pathology International · 2012 · 61 citations

The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma

Satoko Inoda, Rena Morita, Yoshihiko Hirohashi et al. · Experimental and Molecular Pathology · 2010 · 49 citations

, , +9

Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4

Munehide Nakatsugawa, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Cancer Science · 2009 · 32 citations · Full text

, , +14

Rows per page

1–5 of 9